论文部分内容阅读
For most oncology studies,the long-term survival outcome is a typical endpoint for large-scaled confirmatory(phase Ⅲ) studies,while some short-term outcome(e.g.remission rate) that is measured or computed as a specific given time point is generally used as a primary endpoint during the earlier phases(phase Ⅰ or Ⅱ) of the study.